Neurometabolites alteration in the acute phase of mild traumatic brain injury (mTBI): an in vivo proton magnetic resonance spectroscopy (1H-MRS) study by Veeramuthu, Vigneswaran et al.
Neurometabolites alteration in the acute 
phase of mild traumatic brain injury 
(mTBI): an in vivo proton magnetic 
resonance spectroscopy (1H­MRS) study 
Article 
Accepted Version 
Creative Commons: Attribution­Noncommercial­No Derivative Works 4.0 
Veeramuthu, V., Seow, P., Narayanan, V., Wong, J. H. D., 
Tan, L. K., Hernowo, A. T. and Ramli, N. (2018) 
Neurometabolites alteration in the acute phase of mild 
traumatic brain injury (mTBI): an in vivo proton magnetic 
resonance spectroscopy (1H­MRS) study. Academic 
Radiology, 25 (9). pp. 1167­1177. ISSN 1076­6332 doi: 
https://doi.org/10.1016/j.acra.2018.01.005 Available at 
http://centaur.reading.ac.uk/81535/ 
It is advisable to refer to the publisher’s version if you intend to cite from the 
work.  See Guidance on citing .
To link to this article DOI: http://dx.doi.org/10.1016/j.acra.2018.01.005 
Publisher: Elsevier 
All outputs in CentAUR are protected by Intellectual Property Rights law, 
including copyright law. Copyright and IPR is retained by the creators or other 
copyright holders. Terms and conditions for use of this material are defined in 
the End User Agreement . 
www.reading.ac.uk/centaur 
CentAUR 
Central Archive at the University of Reading 
Reading’s research outputs online
Original Investigation
Neurometabolites Alteration in the
Acute Phase of Mild Traumatic Brain
Injury (mTBI):
An In Vivo Proton Magnetic Resonance
Spectroscopy (1H-MRS) Study
Vigneswaran Veeramuthu, PhD*, Pohchoo Seow, MSc*, Vairavan Narayanan, FRCS,
Jeannie Hisu Ding Wong, PhD, Li Kuo Tan, MEng, Aditya Tri Hernowo, PhD,
Norlisah Ramli, FRCR, MBBS
Rationale and Objectives: Magnetic resonance spectroscopy is a noninvasive imaging technique that allows for reliable assessment
of microscopic changes in brain cytoarchitecture, neuronal injuries, and neurochemical changes resultant from traumatic insults. We
aimed to evaluate the acute alteration of neurometabolites in complicated and uncomplicated mild traumatic brain injury (mTBI) pa-
tients in comparison to control subjects using proton magnetic resonance spectroscopy (1H magnetic resonance spectroscopy).
Material and Methods: Forty-eight subjects (23 complicated mTBI [cmTBI] patients, 12 uncomplicated mTBI [umTBI] patients, and
13 controls) underwent magnetic resonance imaging scan with additional single voxel spectroscopy sequence. Magnetic resonance
imaging scans for patients were done at an average of 10 hours (standard deviation 4.26) post injury. The single voxel spectroscopy
adjacent to side of injury and noninjury regions were analysed to obtain absolute concentrations and ratio relative to creatine of the
neurometabolites. One-way analysis of variance was performed to compare neurometabolite concentrations of the three groups, and
a correlation study was done between the neurometabolite concentration and Glasgow Coma Scale.
Results: Significant difference was found in ratio of N-acetylaspartate to creatine (NAA/Cr + PCr) (χ2(2) = 0.22, P < .05) between the
groups. The sum of NAA and N-acetylaspartylglutamate (NAAG) also shows significant differences in both the absolute concentration
(NAA + NAAG) and ratio to creatine (NAA + NAAG/Cr + PCr) between groups (χ2(2) = 4.03, P < .05and (χ2(2) = 0.79, P < .05)). NAA values
were lower in cmTBI and umTBI compared to control group. A moderate weak positive correlation were found between Glasgow Coma
Scale with NAA/Cr + PCr (ρ = 0.36, P < .05 and NAA + NAAG/Cr + PCr (ρ = 0.45, P < .05)), whereas a moderate correlation was seen
with NAA + NAAG (ρ = 0.38, P < .05).
Conclusion: Neurometabolite alterations were already apparent at onset of both complicated and uncomplicated traumatic brain injury.
The ratio of NAA and NAAG has potential to serve as a biomarker reflecting injury severity in a quantifiable manner as it discriminates
between the complicated and uncomplicated cases of mTBI.
Key Words: Neurometabolite; mild Traumatic Brain Injury (TBI); Magnetic Resonance Spectroscopy (MRS); N-acetylaspartate (NAA);
Glasgow Coma Scale (GCS).
© 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.
INTRODUCTION
D eranged metabolites-induced cellular energy crisis isa common occurrence in traumatic head injury (1).The cascading events post trauma may lead to ter-
minal membrane depolarization with excessive release of
excitatory neurotransmitters (2), lysis of the cell membranes
and apoptosis, disrupting various neural connectivity net-
works and consequentially affecting neurocognitive function
or performance (1). Injury severity in mild traumatic brain
injury (mTBI) could be categorized into complicated or
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uncomplicated. A complicated mTBI is differentiated from
an uncomplicated mTBI by the presence of a closed de-
pressed skull fracture or trauma-related intracranial abnormality
or lesion (3,4).
The advent of advanced magnetic resonance imaging (MRI)
techniques in recent years have enabled reliable assessment of
microscopic changes in brain cytoarchitecture, neuronal in-
juries, and neurochemical changes resultant from traumatic
insults. While conventional computed tomography scans and
structural magnetic resonance sequences are usually unable to
detect such physiological and biochemical changes occur-
ring at cellular level (5), magnetic resonance spectroscopy
(MRS) is capable of evaluating metabolic perturbation asso-
ciated with mTBI in vivo.
Several MRS studies showed differences between the semi-
acute, subacute, and chronic stages of mTBI. A study of semi-
acute mTBI with matched controls found elevated
concentrations of glutamate plus glutamine (Gln) signal in the
white matter but reduced gray matter (GM) concentrations
of Gln at grey matter (GM), 13 days postinjury (6). The reduced
GM Gln suggested reduced neural activity. The study also
reported elevated WM concentrations of total creatine (Cr),
believed to be consistent with an upregulation of WM met-
abolic activity and ionic balance restoration of high-energy
phosphates pool for cellular repair.
Between the early subacute and chronic stage of mTBI,
George et al. (2014) reported decreasing trends of thalamic
NAA/Cr (N-acetylaspartate/creatine) and Cho/Cr
(choline/creatine) levels measured in thalamus and centrum
semiovale, corresponding with cognitive measures (5), whereas
Kierans et al. (2014) found increased putaminal myoinositol
(mI), myoinositol/creatine (mI/Cr) and total glutamine/creatine
(Gln/Cr) that reflected complex glial and excitatory re-
sponse to injury in mTBI patients compared to control (7).
At chronic stage of 6 months post trauma, decreased NAA/Cr
and NAA/Cho in white matter (WM) regions were re-
ported in the parietal lobe and occipital lobe, respectively,
together with increased Cho/Cr in the occipital GM (8). There
is a scarcity of data on MRS at the acute stage of mTBI, which
can, in principle, provide useful information on the very early
proton MRS changes. This study aim to investigate the im-
mediate and early neurometabolic changes, in the immediate
aftermath of mTBI (10 hours post trauma). Absolute and the
more clinically available ratio of metabolites from the brain
spectra of patients with complicated mTBI (cmTBI), uncom-
plicated mTBI (umTBI), and healthy controls were also
explored.
METHODS
Participant Recruitment
This prospective study of 48 subjects is composed of 23 cmTBI
patients, 12 umTBI patients, and 13 healthy age-matched sub-
jects as the control group. mTBI patients were recruited from
the emergency department of the hospital for the duration
of 11 consecutive months from April 2013 to March 2014.
Informed consent was obtained from the patients and control
groups. Local institutional review board (UM/EC. 949.15)
ethical approval was obtained for this study. We adopted the
Center for Disease Control’s (USA) definition of mTBI (9).
Mild TBI is generally characterized by one or more of the
following: (1) confusion or disorientation, (2) loss of con-
sciousness for less than 30 minutes, (3) transient focal
neurological signs, and (4) Glasgow Coma Scale (GCS) of 13–
15 upon clinical evaluation. The grouping of injury complexity
as complicated (cmTBI) and uncomplicated (umTBI) groups
was determined by the presence of intracranial lesion and/or
skull fracture, as evaluated by two blinded clinicians, NR (a
neuroradiologist) and VN (a neurosurgeon). Patients with a
normal brain computed tomography scan (no fracture and no
intracranial injury) were classified as umTBI. Details of the
inclusion and exclusion criteria of the study are presented in
Figure 1.
Age matched healthy controls were recruited on volun-
tary basis. They were either staff members of the hospital or
patients’ next of kin. Stringent exclusion criteria as of the pa-
tients were used in the recruitment effort.
Magnetic Resonance Imaging Acquisition
MRI scan was performed on cmTBI and umTBI patients upon
admission using a 3T MRI scanner (Signa HDx, GE Health-
care, Harvey, IL) with a dedicated 8-channel head coil followed
by single voxel spectroscopy (SVS) sequence. The standard
imaging protocol and parameters were as follows: (1) axial T1-
weighted three-dimensional fast spoiled gradient-recalled echo
(FSPGR) with imaging parameters: repetition time
(TR) = 6.7 ms, echo time (TE) = minimum 1.9 ms, field of
view (FOV) = 31 mm, matrix = 256 × 256, slice thick-
ness = 1.2 mm, slice overlap = 0.6 mm with image scan time
of 3 minutes and 48 seconds; and (2) axial T2-weighted fast
spin echo (TR = 4240 ms, TE = 102 ms, FOV = 24 mm,
matrix = 512 × 384, thickness = 5 mm, spacing = 1.5 mm, and
image scan time of 2 minutes and 30 seconds. MRS tech-
nique was performed using a point-resolved single-voxel
spectroscopy probe-p sequence with the following param-
eters: TR = 1500 ms, TE = 35 ms, voxel size = 19 × 19 × 19
mm, slice thickness = 20 mm, number of excitation = 128, and
scan time of 7 minutes. Axial T1W/T2 weighted were used
to position SVS. For cmTBI, SVSs were placed at the white
matter adjacent to injury site and the contralateral normal ap-
pearing white matter (Fig 2c). For umTBI and control, the
SVS were placed in frontal or occipital white matter (Fig 3c
and 4c). The SVS placement was carefully placed so as to avoid
contact with the subcutaneous fat, skull, vasculature, arach-
noid space, and cerebrospinal fluid to mitigate shimming and
water suppression effects. Outer volume saturation bands were
placed over the MRS volume over anatomy of interest to sup-
press signal from fat-containing scalp that might contaminate
the spectrum. No higher order shimming was used in our study.
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Control participants were subjected to the same MRI pro-
tocols as the mTBI patients.
Brain Spectra Analysis
The raw data (P-files) obtained from SVS technique were
postprocessed using LCModel (v6.2, LCMODEL Inc., Ontario,
Canada) to acquire the brain spectra. Metabolite quantifica-
tion of the spectra was obtained through spectral fitting from
the standard basis set of metabolite solutions in vitro (10). We
used the LCModel standard brain spectra setting, which op-
timizes spectrum fitting for normal brains. The LCModel
provides estimation of metabolite quantifications as absolute
concentrations (mmol kg−1) and concentration ratio relative
to creatine.
Spectra Inclusion Criteria
The quality of spectral curve fitting by LCModel and the re-
liability of estimated metabolite concentrations were determined
using the residuals, full width at half-maximum (FWHM) and
Cramér-Rao lower bound (CRLB). The FWHM is an es-
timate of spectrum line width, which characterizes quality of
the in vivo spectrum as a whole. To indicate the quality of
fit, CRLB was used to assess the accuracy of metabolites in
terms of percentage standard deviations (%SD) of the esti-
mated concentration (11). Lower %SD values indicate that
the concentration estimate is more reliable and hence more
accurately represent actual concentration (12). Inclusion cri-
teria for spectra data filtering were as follows: (1) acceptable
spectroscopy curves from visual inspection (13) of individu-
al metabolite profile performed by a neuroradiologist (NR)
who was blinded to the data and diagnosis outcomes of all
the subjects; (2) upper limit acceptance of FWHM < 0.1 part
per million (ppm) (10); and (3) complying to CRLB crite-
rion where %SD < 20%.
A few of the metabolites are quite difficult to resolve from
its counterparts such as choline, NAA, Cr, and Gln (10). They
are normally expressed as sums of concentration pairs where
the sum of concentrations is much more accurate than the
individual concentrations, as reflected in the lower %SD value
for the combined metabolite concentrations compared to in-
dividual concentration (12).
Statistical Analysis
Statistical analysis was performed using SPSS statistical soft-
ware version 22 (IBM Corp., Armonk, NY). One-way analysis
of variance test was carried out to establish neurometabolic
differences among the groups (cmTBI, umTBI, and control)
Figure 1. The inclusion and exclusion cri-
teria of the study. CNS, central nervous
system; GCS, Glasgow Coma Scale; mTBI,
mild traumatic brain injury.
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Figure 2. Example of MRI images and spectra of a cmTBI patient with a Lt temporal-extradural hematoma (arrow) (a) axial T1-weighted
FSPGR, (b) axial T2-weighted, (c) voxel placed at Lt temporal lobe of white matter (indicated by blue box) with voxel size 19 × 19 × 19 mm,
and (d) corresponding neurometabolite profiles after preprocessing using LCModel.10 The red line is the LCModel fit to spectral data. NAA
are labeled at the corresponding peaks. The upper plot is the residuals for indication of LCModel fit. cmTBI, complicated mild traumatic
brain injury; FSPGR, fast spoiled gradient-recalled echo; MRI; magnetic resonance imaging; MRS, magnetic resonance spectroscopy; NAA,
N-acetylaspartate; SVS, single voxel spectroscopy. (Color version of figure is available online.)
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Figure 3. Example of MRI images and spectra of an umTBI patient’s (a) axial T1-weighted FSPGR, (b) axial T2-weighted, (c) voxel placed
at Lt occipital lobe of white matter (indicated by blue box) with voxel size 19 × 19 × 19 mm, and (d) corresponding neurometabolite profiles
after preprocessing using LCModel.10 The red line is the LCModel fit to spectral data. NAA are labeled at the corresponding peaks. The
upper plot is the residuals for indication of LCModel fit. FSPGR, fast spoiled gradient-recalled echo; MRI; magnetic resonance imaging;
MRS, magnetic resonance spectroscopy; NAA, N-acetylaspartate; umTBI, uncomplicated mild traumatic brain injury; SVS, single voxel spec-
troscopy. (Color version of figure is available online.)
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of the absolute concentration and ratio of metabolites. A P
value of < .05 was declared as statistically significant. Post hoc
test was used to determine differences between the groups
as a further analysis. Correlations of neurometabolites between
the three groups and GCS were determined using Pearson
correlation test.
RESULTS
Patient Demography and Clinical Variables
Our study population comprised cmTBI, umTBI, and con-
trols. Clinical variables such as age, years of education, gender,
GCS on admission, loss of consciousness, and post traumatic
amnesia (PTA) were obtained and tabulated as averages. Table 1
shows the demographic characteristics of mTBI patients and
controls. The average MRI scan time for mTBI patients was
10 hours (SD: 4.26) post trauma.
Spectra Analysis
Four spectra were excluded upon visual screening and CRLB
criterion, where one spectrum was from cmTBI group, one
from umTBI, and two from the control group. A few dis-
tinct peaks of metabolite signals were easily measurable. The
metabolites were Glu, glycerophosphocholine (GPC), ino-
sitol (Ins), NAA, sum of NAA and N-acetylaspartylglutamate
(NAA + NAAG), sum of creatine and phosphocreatine
(Cr + PCr), sum of glutamate and glutamine (Glu + Gln), mac-
romolecules at signals around 0.9 ppm (MM09),
macromolecules at signals around 2.0 ppm (MM20), sum
mixture of macromolecules and lipids signals at around 0.9 ppm
(MM09 + Lip09), and 2.0 ppm (MM20 + Lip20). Figure 2d
shows examples of spectra acquired for cmTBI patients.
One-way analysis of variance showed significant differ-
ences (in both the absolute concentration and relative
ratio over total creatine) for the sum of NAA and
NAAG (NAA + NAAG: χ2(2) = 4.03, P < .05 and
NAA + NAAG/Cr + PCr: χ2(2) = 0.79, P < .05) and the rel-
ative ratio of NAA over total creatine (NAA/Cr + PCr:
χ2(2) = 0.22, P < .05) between the three groups (Table 2 and
3). As demonstrated in Figure 2 the NAA peak is lower in
cmTBI patients compared to control in Figure 4. Tukey post
hoc test revealed that absolute metabolite concentration of
NAA + NAAG was statistically lower in cmTBI group com-
pared to control group (P = .036) (Table 4). For the metabolite
ratio NAA + NAAG/Cr + PCr, significant differences were
seen between cmTBI with umTBI (P = .039) and control
(.007), as shown in Table 5.
Associations Between Neurometabolites With Injury
Complexity and GCS
Figure 5 shows the distribution of NAA and its sum across
the three groups and GCS scores. The overall concentra-
tions of NAA and its sum were lower in cmTBI compared
to the other groups, whereas the sum of NAA and NAAG
TABLE 1. Demographic Information According to Study Groups (cmTBI, umTBI, and Control)
Type of Injury
Demographic/Clinical Presentation cmTBI umTBI Control
(n = 23) (n = 12) (n = 13)
Age (year) 28.96 (SD 10.2) 28.25 (SD 7.34) 27.15 (SD 4.88)
Education (years) 10.96 (SD 1.97) 12.25 (SD 2.70) 16.31 (SD 3.28)
% % %
Gender Male 87 83.3 61.5
Female 13 16.7 38.5
GCS on admission GCS 13 21.7 0 n/a
GCS 14 39.1 0 n/a
GCS 15 39.1 100 n/a
Loss of consciousness Yes 95.7 83.3 n/a
No 4.3 16.7 n/a
Post traumatic amnesia None 21.7 33.3 n/a
<1 h 52.2 33.3 n/a
>1 h <24 h 26.1 33.3 n/a
Voxel placement Frontal lobe 8 2 1
Parietal lobe 10 8 12
Temporal lobe 4 0 0
Occipital lobe 1 2 0
cmTBI, complicated mild traumatic brain injury; GCS, Glasgow Coma Scale; umTBI, uncomplicated mild traumatic brain injury; SD, stan-
dard deviation.
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TABLE 2. Descriptive Summary for Absolute Metabolite Concentrations
Metabolites
cmTBI (n = 23)
(ppm)
umTBI (n = 12)
(ppm)
Control (n = 13)
(ppm)
P ValuesMean SD Mean SD Mean SD
Glu 2.817 0.387 2.988 0.371 2.736 0.272 .313
GPC 0.572 0.147 0.685 0.068 0.660 0.109 .166
Ins 1.633 0.347 1.759 0.147 1.576 0.271 .878
NAA 2.690 0.536 2.862 0.541 3.019 0.284 .058
GPC + PCh 0.585 0.129 0.666 0.046 0.660 0.109 .076
NAA + NAAG 3.097 0.775 3.235 0.708 3.620 0.352 .027*
Cr + PCr 1.702 0.340 1.693 0.217 1.766 0.225 .591
Glu + Gln 4.195 0.831 4.150 0.422 3.634 0.328 .120
MM09 1.895 0.574 2.20 0.600 2.319 0.477 .173
MM20 3.105 0.826 3.206 0.448 3.614 0.546 .174
MM09 + Lip09 1.98 0.553 2.440 0.354 2.554 0.692 .144
MM20 + Lip20 3.162 0.8 3.215 0.434 3.736 0.608 .264
cmTBI, complicated mild traumatic brain injury; Cr, creatine; Gln, glutamine; Glu, glutamate; GPC, glycerophosphocholine; Ins, inositol;
MM09 + Lip09, sum mixture of macromolecules and lipids signals at around 0.9 ppm; MM09, macromolecules at signals around 0.9 ppm;
MM20 + Lip20, 2.0 ppm; MM20, macromolecules at signals around 2.0 ppm; NAA, N-acetylasparte; NAAG, N-acetylaspartylglutamate; PCh,
phosphocholine; PCr, phosphocreatine; ppm, parts per million; SD, standard deviation; umTBI, uncomplicated mild traumatic brain injury.
* P < .05.
TABLE 3. Descriptive Summary for Relative Metabolite Concentrations Over Total Creatine
Metabolites (/Cr + PCr)
cmTBI (n = 23)
(ppm)
umTBI (n = 12)
(ppm)
Control (n = 13)
(ppm)
P ValuesMean SD Mean SD Mean SD
Glu 1.699 0.293 1.782 0.250 1.567 0.215 .222
GPC 0.343 0.1 0.395 0.035 0.374 0.049 .705
Ins 0.978 0.219 1.050 0.101 0.894 0.129 .291
NAA 1.593 0.202 1.68 0.163 1.72 0.125 .025*
GPC + PCh 0.354 0.097 0.397 0.035 0.374 0.049 .771
NAA + NAAG 1.82 0.282 1.895 0.287 2.059 0.11 .004*
Glu + Gln 2.464 0.435 2.352 0.376 2.051 0.336 .139
MM09 1.098 0.249 1.278 0.253 1.289 0.216 .402
MM20 1.796 0.332 1.882 0.096 2.028 0.361 .282
MM09 + Lip09 1.149 0.229 1.367 0.191 1.418 0.330 .400
MM20 + Lip20 1.831 0.307 1.889 0.099 2.097 0.399 .619
cmTBI, complicated mild traumatic brain injury; Cr, creatine; Gln, glutamine; Glu, glutamate; GPC, glycerophosphocholine; Ins, inositol;
MM09 + Lip09, sum mixture of macromolecules and lipids signals at around 0.9 ppm; MM09, macromolecules at signals around 0.9 ppm;
MM20 + Lip20, 2.0 ppm; MM20, macromolecules at signals around 2.0 ppm; NAA, N-acetylasparte; NAAG, N-acetylaspartylglutamate; PCh,
phosphocholine; PCr, phosphocreatine; ppm, parts per million; SD, standard deviation; umTBI, uncomplicated mild traumatic brain injury.
* P < .05.
TABLE 4. The Post Hoc Test for Absolute Metabolite Concentration NAA + NAAG
I Group J Group Mean Difference (I-J) Std Error Sig
95% CI
Lower Bound Upper Bound
cmTBI umTBI −0.502 0.255 0.132 −1.12 0.116
Control −0.636 0.248 0.036* −1.238 −0.339
umTBI cmTBI 0.502 0.255 0.259 −0.095 0.459
Control −0.134 0.287 0.132 −0.116 1.12
CI, confidence interval; cmTBI, complicated mild traumatic brain injury; NAA, N-acetylasparte; NAAG, N-acetylaspartylglutamate; umTBI,
uncomplicated mild traumatic brain injury.
* Indicates significant difference at P < .05.
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Figure 4. Example of MRI images and spectra of a control patient’s (a) axial T1-weighted FSPGR, (b) axial T2-weighted, (c) voxel placed
at Rt occipital lobe of white matter (indicated by blue box) with voxel size 19 × 19 × 19 mm, and (d) corresponding neurometabolite profiles
after preprocessing using LCModel.10 The red line is the LCModel fit to spectral data. NAA are labeled at the corresponding peaks. The
upper plot is the residuals for indication of LCModel fit. FSPGR, fast spoiled gradient-recalled echo; MRI; magnetic resonance imaging;
MRS, magnetic resonance spectroscopy; NAA, N-acetylaspartate; SVS, single voxel spectroscopy. (Color version of figure is available online.)
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showed increasing trend with GCS. A significant weak pos-
itive correlation was seen between NAA and its sum with the
three groups (ρ = 0.35–0.44, P < .05). Weak positive corre-
lations were also found between GCS with NAA/Cr + PCr
(ρ = 0.36, P < .05), NAA + NAAG/Cr + PCr (ρ = 0.45,
P < .05), and NAA + NAAG (ρ = 0.38, P < .05).
DISCUSSION
Spectroscopic evaluation of metabolic profiles could provide
valuable information about the degree of neuronal injury as
reflected by the changes in neurometabolite concentrations.
Hence, in this study, we set out to examine the hyperacute
neurometabolic alteration hypothesized to occur in the early
hours of a traumatic insult (mTBI) using MRS imaging mo-
dality. These mTBI patients generally underwent scanning
within an average of 10 hours post trauma to minimize pos-
sible confounding factors such as ongoing secondary damage
or recovery mechanisms. Secondary injuries like diffuse axonal
injury, inflammation, edema, apoptosis, excitotoxicity, and mi-
tochondrial dysfunction can cause fluctuations in the metabolite
profiles at a later stage of brain injury (5). We found that
TABLE 5. The Post Hoc Test for Metabolite Ratio NAA + NAAG/Cr + PCr
I Group J Group Mean Difference (I-J) Std Error Sig
95% CI
Lower Bound Upper Bound
cmTBI umTBI −0.227 0.899 0.039* −0.445 0.009
Control −0.279 0.088 0.007* −0.491 −0.066
umTBI cmTBI 0.227 0.090 0.039* 0.009 0.445
Control −0.052 0.101 0.866 −0.297 0.193
CI, confidence interval; cmTBI, complicated mild traumatic brain injury; NAA + NAAG/Cr + PCr, N-acetylasparte and
N-acetylaspartylglutamate/creatine and phosphocreatine; umTBI, uncomplicated mild traumatic brain injury.
* Indicates significant difference at P < .05.
Figure 5. The box plots of neurometabolites distributions (a) NAA/Cr + PCr, (b) NAA + NAAG, and (c) NAA + NAAG/Cr + PCr across the
groups, and (d) NAA/Cr + PCr, (e) NAA + NAAG, and (f) NAA + NAAG/Cr + PCr across the GCS scores. The values beside the boxplots de-
scribe the median value of the neurometabolites. GCS, Glasgow Coma Scale; NAA/Cr + PCr, N-acetylaspartate to creatine and phosphocreatine;
NAA + NAAG, N-acetylasparte and N-acetylaspartylglutamate; NAA + NAAG/Cr + PCr, N-acetylasparte and N-acetylaspartylglutamate/creatine
and phosphocreatine.
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neurometabolite alterations were already apparent at this early
phase. Previous studies in this field has revealed microstruc-
tural changes which occur within hours after the initial insult
affecting WM integrity, resulting in neuropsychological im-
pairments (14).
The absolute metabolite concentrations of total NAA and
NAAG and ratio metabolite concentrations of NAA and its
counterpart over creatine (NAA/Cr + PCr and
NAA + NAAG/Cr + PCr) showed statistically significant
changes in this study. The NAA and its related compound,
NAAG also demonstrated statistically significant difference
among the patients with cmTBI in comparison to the healthy
controls. Additionally, we also found that the spread of NAA
values were wider in cmTBI group (Fig 5), suggesting pos-
sible disease heterogeneity among patients with mTBI. NAA
is believed to be the source of metabolic acetate for oligo-
dendrocyte myelination and serves as a precursor for the
synthesis of the neurotransmitter NAAG (15). Levels of NAA
and NAAG are dysregulated in various disease states associ-
ated with aberrant oligodendrocyte differentiation. Traumatic
insult to the brain, however, induces the disturbance of neu-
ronal integrity that results in mitochondrial dysfunction and
NAA synthesis perturbation (1,5).Various studies have re-
ported that the depression of NAA and NAAG levels due to
neurometabolic impairment in concussed subjects is a common
occurrence (16–18).
The NAA also serves as an osmolyte in neuronal tissues
and a source of acetate for myelin synthesis in the glial cells,
a process that is usually disrupted in the aftermath of a trau-
matic insult (19). The sudden decrease or reduction in NAAG
concentration thereafter causes a sudden surge in glutamate
generation that consequentially leads to mitochondrial dys-
function (18), affecting the neuronal homeostasis and viability.
Hence, the significant downward trend of NAA in cmTBI
and its association with clinical markers such as the GCS
scores as seen in our study cannot understate the importance
of NAA as a parameter for brain injury detection. Although
the complete pathophysiology of NAA reduction and altered
level of consciousness post trauma is not readily known, its
viability as a marker has been established and is possibly at-
tributed to substantial cellular (neuronal/axonal) injury in
patients with mTBI (6,20). Hence, the importance of early
measurement of NAA levels post trauma (less than 48 hours)
has been consistently noted as a good marker for disease se-
verity classification and prognostication, and cannot be ignored
for long (6,21–23).
The major limitation of our study is the small sample size
especially in the umTBI group in comparison to the cmTBI
group. Heterogeneity of location may confound interpreta-
tion of the spectroscopy, as metabolite ratios are known to
vary from brain region to brain region. Our study did not
take into account the widespread global effect of tissue damage
on the entire brain parenchyma because of limitation of place-
ment of ROI (region of interest) in the SVS. A longer follow-
up data would be necessary to establish the usefulness of NAA
for diagnosis and prognosis of mTBI.
CONCLUSION
A decline in NAA and NAAG ratio was associated with de-
creasing injury severity (based on GCS), at the acute stage
of an evolving brain injury in mTBI. This study revealed the
potential application of NAA and NAAG as a biomarker to
discriminate between the mTBI subgroups (complicated and
uncomplicated cases) in a more quantifiable manner. The
knowledge of early onset neurometabolite alterations and its
correlations with injury severity adds another degree of in-
tricacy to the understanding of mTBI mechanism. Future work
in this area should explore the neurometabolic changes in all
injury severities (ie, mild, moderate, and severe head injury).
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